Antibe Announces TSX Delisting Review - Business Wire
ATBPF Stock | USD 0.22 0.00 0.00% |
Roughly 56% of Antibe Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Antibe Therapeutics pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Antibe Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Antibe Therapeutics stock news signals to limit their universe of possible portfolio assets.
Antibe Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Antibe daily returns and investor perception about the current price of Antibe Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Antibe |
Antibe Announces TSX Delisting Review Business Wire
Read at news.google.com
Antibe Therapeutics Fundamental Analysis
We analyze Antibe Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Antibe Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Antibe Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Antibe Therapeutics is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Antibe Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Antibe Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Antibe Therapeutics could also be used in its relative valuation, which is a method of valuing Antibe Therapeutics by comparing valuation metrics with similar companies.
Peers
Antibe Therapeutics Related Equities
ANEB | Anebulo Pharmaceuticals | 7.64 | ||||
ADAG | Adagene | 6.39 | ||||
PEPG | PepGen | 6.37 | ||||
RZLT | Rezolute | 4.90 | ||||
PHVS | Pharvaris | 3.29 | ||||
MOLN | Molecular Partners | 2.04 | ||||
AVTE | Aerovate Therapeutics | 1.50 | ||||
MNOV | MediciNova | 3.36 | ||||
PMVP | Pmv Pharmaceuticals | 4.73 | ||||
HCWB | HCW Biologics | 9.80 |
Complementary Tools for Antibe Pink Sheet analysis
When running Antibe Therapeutics' price analysis, check to measure Antibe Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antibe Therapeutics is operating at the current time. Most of Antibe Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antibe Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antibe Therapeutics' price. Additionally, you may evaluate how the addition of Antibe Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
CEOs Directory Screen CEOs from public companies around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |